Browsing tag:

dexamethasone


Thalidomide, known as the brand name Thalomid, is a known therapy for patients who are newly diagnosed with multiple myeloma. Patients who have been recently diagnosed with multiple myeloma are often given a combination treatment of Thalidomide and dexamethasone. Recently, research has shown that there are new possible uses for Thalidomide to treat a variety of[…]

Read More

Lenalidomide created quite a stir on Wall Street on July 11, 2013 when shares of Celgene’s Revlimid, the brand name of Lenalidomide, soared. The frenzy occurred after Celgene released data from the Phase 3 study of Lenalidomide, revealing  the great success of this blood cancer drug. Lenalidomide proved in Phase 3 studies to effectively halt[…]

Read More

Glatiramer, CAS# 28704-27-0, and Glatiramer Acetate, CAS# 147245-92-9, are also known as Copaxone. In the spotlight recently, Copaxone’s patent is due to expire on May 24, 2014. The flurry of interest regarding Copaxone follows the devastating diagnosis of Multiple Sclerosis for beloved reality star Jack Osbourne. In mid June of 2012 reports surfaced about Jack’s[…]

Read More